Pharmaceutical composition containing clomipramine and its manufacturing method

The present invention provides a pharmaceutical preparation comprising clomipramine having improved stability and a method for manufacturing the pharmaceutical preparation, wherein the pharmaceutical preparation comprises clomipramine or pharmaceutically acceptable salts thereof (preferably, clomipr...

Full description

Saved in:
Bibliographic Details
Main Authors KIM JUNG HWA, LEE DONG JIN, PARK HYUN JUNG, KWAK SEONG SHIN, LEE, BONG SANG, JEON HONG RYEOL
Format Patent
LanguageEnglish
Korean
Published 11.02.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention provides a pharmaceutical preparation comprising clomipramine having improved stability and a method for manufacturing the pharmaceutical preparation, wherein the pharmaceutical preparation comprises clomipramine or pharmaceutically acceptable salts thereof (preferably, clomipramine hydrochloride) as a first active ingredient, and sildenafil or pharmaceutically acceptable salts thereof (preferably, sildenafil citrate) as a second active ingredient. Specifically, the present invention provides: a pharmaceutical preparation comprising both of the active ingredients, manufactured by using a wet granulation method, wherein the pharmaceutical preparation comprises clomipramine having improved stability, and a method for manufacturing the pharmaceutical preparation. 제1유효성분으로 클로미프라민 또는 이의 약학적으로 허용 가능한 염(바람직하게는 클로미프라민염산염)을 포함하고, 제2유효성분으로 실데나필 또는 이의 약학적으로 허용 가능한 염(바람직하게는 실데나필구연산염)을 포함하는 약학 제제에 있어서, 본 발명은 클로미프라민의 안정성이 개선된 약학 제제 및 이러한 약학 제제를 제조하는 방법을 제공한다. 특히, 본 발명은 상기 두 가지 유효성분을 포함하고, 습식과립법을 이용하여 제조되는 약학 제제에 있어서, 클로미프라민의 안정성이 개선된 약학 제제 및 이러한 약학 제제를 제조하는 방법을 제공한다.
Bibliography:Application Number: KR20220011066